GLP-1RA can also play a cardioprotective role by increasing autophagy, inhibiting cardiomyocyte apoptosis, reducing the expression of inflammation-related proteins (30), reducing cardiomyocyte apoptosis induced by hyperglycemia (31), and improving myocardial energy metabolism
The FDAs Pharmacy Compounding Advisory Committee (PCAC) is meeting Thursday and Friday to review some of the controversial, popular peptide injections and discuss whether compounding pharmacies should be able to dispense them
Together, these two mechanisms seem to work jointly to enhance ROS levels and lead to cell death in cisplatin-resistant lung cancer cells
Some physicians use BPC-157 only during the GLP-1 titration window (the first 3 to 4 months when GI side effects are highest), then taper off once the maintenance dose is stable and well-tolerated
As discussed above, elevated circulating TMAO levels correlate with a higher risk of adverse cardiovascular events